2508 Three-arm phase II randomized trial of docetaxel monotherapy or combined with ramucirumab or icrucumab in second-line locally advanced or metastatic urothelial carcinoma
Petrylak D, Tagawa S, Kohli M, Eisen A, Canil C, Sridhar S, Spira A, Yu E, Burke J, Shaffer D, Pan C, Kim J, Aragon-Ching J, Tang S, Zhang H, Cavanaugh C, Kauh J, Walgren R, Chi K. 2508 Three-arm phase II randomized trial of docetaxel monotherapy or combined with ramucirumab or icrucumab in second-line locally advanced or metastatic urothelial carcinoma. European Journal Of Cancer 2015, 51: s476. DOI: 10.1016/s0959-8049(16)31329-6.Peer-Reviewed Original Research